The DOI matches its Crossref record, with a small difference in title or year; 54 of the 55 references it cites were found in a registry or an index.
The Funny Current: Cellular Basis for the Control of Heart Rate
Abstract
The 'funny' (pacemaker, I(f)) current, first described almost 30 years ago in sinoatrial node (SAN) myocytes, is a mixed sodium/potassium inward current, activated on hyperpolarisation in the diastolic range of voltages. 'Funny' (f) channels are activated by intracellular cyclic adenosine monophosphate (cAMP) concentrations according to a mechanism mediating regulation of heart rate by the autonomic nervous system, as well as by voltage hyperpolarisation. Structural subunits of native f-channels are the hyperpolarisation-activated cyclic nucleotide-gated (HCN) channels; of the four HCN isoforms known, HCN4 is the most highly expressed in SAN tissue. The I(f) current is a natural target in the search for drugs aimed specifically at affecting heart rate, given its function in pacemaking. Increased heart rate has a negative influence on clinical outcome in patients with cardiovascular disease, and indeed is also an established risk factor for cardiovascular and all-cause mortality in the general population. Clearly, therefore, independent reduction of heart rate, through inhibition of the I(f) current, appears to be a suitable therapeutic option for patients with ischaemic heart disease.beta-Adrenoceptor antagonists (beta-blockers) reduce intracellular cAMP levels, and a substantial part of their negative chronotropic effect is therefore attributable to a reduction of the I(f) current. However, neither beta-blockers nor Ca(2+) channel antagonists, both of which have traditionally been used to reduce myocardial ischaemia, are 'pure' heart rate-lowering drugs. These agents may, in fact, have adverse cardiovascular and noncardiovascular effects.Conversely, the novel heart rate-reducing agent ivabradine is a specific blocker of f-channels, hence a selective inhibitor of the pacemaker I(f) current in the SAN. Ivabradine slows heart rate by reducing the I(f) current-regulated steepness of the diastolic depolarisation in SAN myocytes, thereby increasing diastolic duration, without altering action potential duration or causing negative inotropy. As such, ivabradine is particularly useful in patients with chronic stable angina pectoris. Further clinical studies are ongoing to evaluate the efficacy of ivabradine in patients with coronary heart disease, left ventricular dysfunction and heart failure. This short article reviews the current state of knowledge of the properties of the 'funny' current in relation to exploitation of the I(f) function in pacemaking generation and modulation for the pharmacological control of heart rate.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ivabradine selectively inhibits the depolarizing If current in the sinus node.”
From CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction (2021) · cites this paper as [59]
In the citing paper
“It thus requires sinus rhythm to provide its pharmacological effect.”
From CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction (2021) · cites this paper as [59]
In the citing paper
“In contrast to β-blockers, ivabradine decreases heart rate without lowering BP or myocardial contractility.”
From CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction (2021) · cites this paper as [59]
Citations
Cites
Hyperpolarization-Activated Cation Currents: From Molecules to Physiological Function
Robinson, R. B., & Siegelbaum, S. A. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142734 · Cited by 1,177
Heart-Rate Profile during Exercise as a Predictor of Sudden Death
Jouven, X., Empana, J.-P., Schwartz, P. J., Desnos, M., Courbon, D., & Ducimetière, P. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043012 · Cited by 1,005
A family of hyperpolarization-activated mammalian cation channels
Ludwig, A., Zong, X., Jeglitsch, M., Hofmann, F., & Biel, M. (1998) · Nature · doi:10.1038/31255 · Cited by 943
Pacemaker Mechanisms in Cardiac Tissue
DiFrancesco, D. (1993) · Annual Review of Physiology · doi:10.1146/annurev.ph.55.030193.002323 · Cited by 862 · cited 3×
“Increased heart rate[1] Decreased heart rate[1]”
BackgroundSelf-citationDirect activation of cardiac pacemaker channels by intracellular cyclic AMP
DiFrancesco, D., & Tortora, P. (1991) · Nature · doi:10.1038/351145a0 · Cited by 850
Self-citationA model of cardiac electrical activity incorporating ionic pumps and concentration changes
Di Francesco, D., & Noble, D. (1985) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1985.0001 · Cited by 827
Self-citationDiaz, A., Bourassa, M. G., Guertin, M.-C., & Tardif, J.-C. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi190 · Cited by 790 · cited 1×
“The funny current, with limited coronary blood flow.[8,9] It thus follows discovered nearly 30 years ago, underlies generation that reduction of heart rate, independent of other of the diastolic depolarisation phase of the action effects on the cardiovascular system, may be a viapotential, and is ultimately responsibl…”
BackgroundIdentification of a Gene Encoding a Hyperpolarization-Activated Pacemaker Channel of Brain
Santoro, B., Liu, D. T., Yao, H., Bartsch, D., Kandel, E. R., Siegelbaum, S. A., & Tibbs, G. R. (1998) · Cell · doi:10.1016/s0092-8674(00)81434-8 · Cited by 704
How does adrenaline accelerate the heart?
BROWN, H. F., DIFRANCESCO, D., & NOBLE, S. J. (1979) · Nature · doi:10.1038/280235a0 · Cited by 584 · cited 5×
“[42,43] Curiously enough, although these first observations and the first description of the funny current[14] occurred at the same time, the realisation that bradycardic agents worked via a block of the funny current occurred much later.”
BackgroundInfluentialSelf-citationTardif, J.-C., Ford, I., Tendera, M., Bourassa, M. G., & Fox, K. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi586 · Cited by 582
Research works printed but not linked: 6
- Ferrari, 2002, Medicographia, 24, 201
- Diaz, 2005, Medicographia, 27, 82
- Lipsius, 2001, News Physiol Sci, 16, 101
- DiFrancesco, 2002, Medicographia, 24, 218
- Borer, 2005, Medicographia, 27, 44
- Purcell, 2005, Medicographia, 27, 51
Cited by
Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations
Boudoulas, K. D., Borer, J. S., & Boudoulas, H. (2015) · Cardiology · doi:10.1159/000435947 · Cited by 1,938
Self-citationEzekowitz, J. A., O'Meara, E., McDonald, M. A., Abrams, H., Chan, M., Ducharme, A., Giannetti, N., Grzeslo, A., Hamilton, P. G., Heckman, G. A., et al. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.08.022 · Cited by 676
Human islets contain four distinct subtypes of β cells
Dorrell, C., Schug, J., Canaday, P. S., Russ, H. A., Tarlow, B. D., Grompe, M. T., Horton, T., Hebrok, M., Streeter, P. R., Kaestner, K. H., et al. (2016) · Nature Communications · doi:10.1038/ncomms11756 · Cited by 378
McDonald, M., Virani, S., Chan, M., Ducharme, A., Ezekowitz, J. A., Giannetti, N., Heckman, G. A., Howlett, J. G., Koshman, S. L., Lepage, S., et al. (2021) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2021.01.017 · Cited by 287
“In contrast to b-blockers, ivabradine decreases heart rate without lowering BP ormyocardial contractility.(59) The”
ResultMustafa, S. J., Morrison, R. R., Teng, B., & Pelleg, A. (2009) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-89615-9_6 · Cited by 251
Metadata
- Authors
- DiFrancesco, D., & Borer, J. S.
- Affiliations
- University of Milan (IT)
- NewYork–Presbyterian Hospital (US)
- Corresponding author
- DiFrancesco, Dario
- Venue
- Drugs
- Published
- 2007
- Volume
- 67
- Issue
- Supplement 2
- Pages
- 15-24
- ISSN
- 0012-6667 (ISSN-L)
- OpenAlex
- W2066304445
- Cited by
- 155
- References
- 55
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 7 · 2023: 4 · 2022: 7 · 2021: 9 · 2020: 8 · 2019: 12 · 2018: 13 · 2017: 12 · 2016: 7 · 2015: 8 · 2014: 4 · 2013: 8 · 2012: 8
- FWCI
- 6.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drugs (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Keywords
- hyperpolarization-activated current, HCN channels, HCN4, sinoatrial node, pacemaking, rate control, ivabradine, beta-blockers, negative chronotropic effect, ischemic heart disease, stable angina, cyclic AMP
- MeSH terms
- Ivabradine, Cyclic AMP, Animals, Benzazepines, Electrophysiology, Heart Rate, Humans, Muscle Proteins, Sinoatrial Node, Potassium Channels, Myocardial Ischemia, Protein Isoforms, Myocytes, Cardiac, Cyclic Nucleotide-Gated Cation Channels, Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Funny Current: Cellular Basis for the Control of Heart Rate. https://app.cochat.ai/papers/10.2165/00003495-200767002-00003
- The paper
- DiFrancesco, D., & Borer, J. S. (2007). The Funny Current: Cellular Basis for the Control of Heart Rate. Drugs. https://doi.org/10.2165/00003495-200767002-00003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.